甘露醇联合地塞米松对感染性脑水肿患者相关指标的影响 点击下载
| 论文标题： | 甘露醇联合地塞米松对感染性脑水肿患者相关指标的影响 |
| 英文标题： | |
| 中文摘要： | 目的：探讨甘露醇联合地塞米松对感染性脑水肿患者相关指标的影响。方法：回顾性分析120例感染性脑水肿患者资料，按治疗方案的不同分为对照组（60例）和观察组（60例）。对照组患者给予呋塞米注射液20 mg+20％甘露醇注射液1 g/（kg·次）+0.9％氯化钠注射液10 mL，静脉滴注，每6 h 1次，用药3 d后视患者病情调整剂量。观察组患者给予地塞米松磷酸钠注射液10～20 mg+20％甘露醇注射液1 g/（kg·次）+0.9％氯化钠注射液10 mL，静脉滴注，每6 h 1次，用药3 d后视患者病情调整剂量。两组均以7 d为1个疗程，共治疗2个疗程。观察两组患者治疗前后一氧化氮（NO）、白细胞介素1（IL-1）、肿瘤坏死因子α（TNF-α）水平，病死率、后遗症及不良反应发生情况。结果：治疗前，两组患者NO、IL-1、TNF-α水平比较，差异均无统计学意义（P＞0.05）。治疗后，两组患者NO、IL-1、TNF-α水平均显著低于同组治疗前，且观察组显著低于对照组，差异均有统计学意义（P＜0.05）。观察组患者病死率、后遗症及不良反应发生率均显著低于对照组，差异均有统计学意义（P＜0.05）。结论：甘露醇联合地塞米松能降低感染性脑水肿患者的炎症因子水平、后遗症发生率及病死率，且未增加不良反应的发生。 |
| 英文摘要： | OBJECTIVE： To investigate the effects of mannitol combined with dexamethasone on related indexes of patients with infectious brain edema. METHODS： A total of 120 patients with infectious cerebral edema were divided into control group （60 cases） and observation group （60 cases） according to therapy plan. Control group was given Furosemide injection 20 mg+20％ Mannitol injection 1 g/（kg·time）+0.9％ Sodium chloride injection 10 mL intravenously， every 6 h， 3 days later adjusting drug dose according to the disease condition of patients. Observation group was given Dexamethasone injection 10-20 mg+20％ Mannitol injection 1 g/（kg·time）+ 0.9％ Sodium chloride injection 10 mL intravenously， every 6 h， 3 days later adjusting drug dose according to the disease condition of patients. A treatment course lasted for 7 d， and both groups were treated for 2 courses of treatment. The levels of NO， IL-1 and TNF-α， mortality and the occurrence of sequelae before and after treatment as well as the occurrence of ADR were observed in 2 groups. RESULTS： Before treatment， there was no statistical significance in the levels of NO， IL-1 or TNF-α between 2 groups （P＞0.05）. After treatment， the levels of NO， IL-1 and TNF-α in 2 groups were significantly lower than before treatment， and the observation group was significantly lower than the control group， with statistical significance （P＜0.05）. The incidence of mortality， sequelae and ADR in observation group were significantly lower than control group， with statistical significance （P＜0.05）. CONCLUSIONS： Mannitol combined with dexamethasone can reduce inflammatory factor level， the incidence of sequelae and mortality， without increasing the incidence of ADR. |
| 期刊： | 2017年第28卷第24期 |
| 作者： | 陆蒂青，张冬云，闪海霞 |
| 英文作者： | LU Diqing，ZHANG Dongyun，SHAN Haixia |
| 关键字： | 甘露醇；地塞米松；呋塞米；感染性脑水肿；炎症因子；安全性 |
| KEYWORDS： | Mannitol； Dexamethasone； Furosemide； Infectious brain edema； Inflammatory factor； Safety |
| 总下载数： | 81次 |
| 本日下载数： | 2次 |
| 本月下载数： | 81次 |
| 文件大小： | 619.60Kb |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！